Cargando…
The progress of peptide vaccine clinical trials in gynecologic oncology
Peptide vaccine are a type of immunotherapy that are synthesized according to the amino acid sequence of known or predicted tumor antigen epitopes. They are safe and well tolerated and have shown exciting results in gynecologic oncology. However, no peptide vaccine has yet been licensed in this fiel...
Autores principales: | Tang, Mi, Cai, Jiang-Hui, Diao, Hao-Yang, Guo, Wen-Mei, Yang, Xiao, Xing, ShaSha |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450897/ https://www.ncbi.nlm.nih.gov/pubmed/35687860 http://dx.doi.org/10.1080/21645515.2022.2062982 |
Ejemplares similares
-
Vaccines as a preventive tool for substance use disorder: A systematic review including a meta-analysis on nicotine vaccines’ immunogenicity
por: Scendoni, Roberto, et al.
Publicado: (2022) -
Therapeutic potential of mesenchymal stem cells for refractory inflammatory and immune skin diseases
por: Hua, Chunting, et al.
Publicado: (2022) -
Immunotherapy of glioblastoma: Recent advances and future prospects
por: Yuan, Boyang, et al.
Publicado: (2022) -
Development and evaluation of a tetravalent botulinum vaccine
por: Shi, Dan-Yang, et al.
Publicado: (2022) -
Review of bimekizumab in the treatment of psoriasis
por: Koppu, Sindhuja, et al.
Publicado: (2022)